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Abstract—Molecularly targeted contrast enhanced 
ultrasound (mCEUS) is a clinically promising approach for 
early cancer detection through targeted imaging of VEGFR2 
(KDR) receptors. We have developed computational 
enhancement techniques for mCEUS tailored to address 
the unique challenges of imaging contrast accumulation in 
humans.  These techniques utilize dynamic analysis to 
distinguish molecularly bound contrast agent from other 
contrast-mode signal sources, enabling analysis of 
contrast agent accumulation to be performed during 
contrast bolus arrival when the signal due to molecular 
binding is strongest.   
Applied to the 18 human patient examinations of the first-
in-human molecular ultrasound breast lesion study, 
computational enhancement improved the ability to 
differentiate between pathology-proven lesion and 
pathology-proven normal tissue in real-world human 
examination conditions that involved both patient and 
probe motion, with improvements in contrast ratio between 
lesion and normal tissue that in most cases exceed an order 
of magnitude (10x).  Notably, computational enhancement 
eliminated a false positive result in which tissue leakage 
signal was misinterpreted by radiologists to be contrast 
agent accumulation. 
 
Index Terms—Contrast-Enhanced Ultrasound, CEUS, 
BR-55, Background Subtraction, Biomedical Imaging, 
Molecular Imaging, Molecularly Targeted Ultrasound, 
mCEUS.  
I. INTRODUCTION 
OLECULARLY targeted ultrasound contrast agents 
preferentially bind to a molecular target of interest, 
accumulating in the body and generating a signal that is 
observable by imaging techniques such as contrast-mode 
ultrasound [15]. One of the major challenges when imaging 
contrast agent accumulation is that the signal from 
accumulating contrast agent is confounded by signal from other 
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sources. Signal from contrast-mode tissue leakage, such as 
connective tissue that appears to be contrast agent; signal from 
contrast agent that has accumulated non-specifically for reasons 
other than molecular binding; and signal from contrast agent 
particles that are freely flowing in the bloodstream, are all 
intermixed with the signal of accumulating contrast agent 
associated with molecular binding [2,16]. We have employed 
computational enhancement techniques to de-confound these 
intermixed signals, enabling imaging during the period of high 
free-flow of contrast agent in the bloodstream, near the time of 
contrast bolus arrival, when the molecular signal from specific 
binding is strongest.  
We demonstrate these techniques using data acquired by 
Willmann et al. [1] during the first-in-human molecularly 
targeted ultrasound study of suspected human breast cancer 
lesions, which employed BR-55, a microbubble contrast agent 
functionalized to molecularly bind to the KDR protein, as an 
indication of angiogenesis activity. Data analysis in that study 
was performed manually by skilled radiologists, primarily 
using data acquired several minutes after arrival of the contrast 
bolus, after the flow of free contrast agent in the bloodstream 
M 
Case #9
Figure 1: Results of Computational Enhancement.  Left: raw mCEUS 
image 36 seconds after contrast bolus arrival. Right: Computational 
enhancement results following tissue leakage and flow disambiguation.  
The outlined region on the left in both images corresponds to pathology 
proven normal tissue, while the outlined region on the right 
corresponds to pathology-proven lesion tissue.  (case #9-129)   
  
had largely subsided. We show that use of computational 
enhancement can make it practical to image earlier, during and 
shortly after contrast bolus arrival when the signal is strongest, 
before substantial unbinding or bubble destruction occurs. 
Another advantage to imaging during contrast bolus arrival is 
that accumulation rate information can be captured to help 
disambiguate specific binding to the molecular target vs. non-
specific accumulation. 
Our computational enhancement pipeline explicitly models 
and removes tissue leakage signal. It also provides a qualitative 
estimate of the amount of accumulated contrast agent present, 
even during periods of high flow when the molecularly bound 
microbubble signal cannot be directly observed because it is 
obscured by signal from free-flowing contrast agent. 
Computational enhancement provides substantial 
improvements in contrast ratio between pathology-proven 
lesion and pathology-proven non-lesion tissues, as illustrated 
by the computational enhancement results shown in Figure 1.  
II. IMAGING CHALLENGES 
Imaging of contrast agent accumulation in humans poses 
unique challenges relative to imaging in small laboratory 
animals. First, the imaging geometries and power levels 
involved induce significant amounts of tissue leakage signal, 
typically associated with connective tissue that has similar 
resonant properties to contrast agent, and hence can evade the 
harmonic filters employed in commercial ultrasound machines. 
The most effective approaches to distinguish and eliminate 
signal due to tissue leakage involve destruction of the 
microbubble contrast agent using a high energy ultrasound 
pulse [16]. Any signal that remains after bubble destruction is 
due to tissue leakage. Due to safety concerns about ultrasound-
induced bubble destruction potentially causing damage to small 
blood vessels [3], destructive protocols were not employed in 
the human breast imaging study, necessitating development of 
an alternative, non-destructive method to distinguish 
accumulating contrast agent from tissue leakage. 
When imaging at modest frame rates during periods of high 
flow of microbubbles in the bloodstream, the signal from 
specifically-bound accumulating microbubbles is masked by 
signal from flowing contrast agent in every captured image 
frame. Thus clever techniques for non-destructively 
disambiguating between flowing and stationary microbubbles, 
such as the Minimum-Intensity-Projection methods described 
in [2], which rely on at least occasional absence of flowing 
contrast agent, are not effective during periods of high flow. To 
address this issue, we developed a statistical method that 
estimates the degree of accumulation, even during periods of 
high flow when it cannot be directly observed. 
III. RELATED WORK 
A. Estimation based on Intensity Projection 
In situations for which the flow of contrast agent is modest or 
has partially subsided, several minutes after contrast bolus 
arrival, we have found that the Minimum Intensity Projection 
(MinIP) and Percent Intensity Projection (PerIP) techniques 
described in [2] are highly effective for removing signal 
associated with flowing contrast agent. These techniques take 
advantage of the fact that intensity increases associated with 
flowing contrast agent will only be present in some of the 
frames, so occasionally a frame without flowing contrast agent 
will be captured. Taking the minimum intensity value across a 
multi-frame time window reveals the portion of the intensity 
that is associated with bound contrast agent, since the presence 
of flowing contrast agent occurs only occasionally. However, 
when imaging in the presence of high concentrations of flowing 
contrast agent, the signal due to accumulation is typically not 
independently observable in any frame, causing the MinIP and 
PerIP techniques to lead to false positive indications in which 
flowing contrast agent is mistaken to be accumulated contrast 
agent. 
B. Multi-compartment Models 
Turco et al.[11] introduce a flow modeling approach that fits 
a multi-compartment model of the rate of the anticipated flow 
dynamics and rate of accumulation of contrast agent.  This 
approach assumes a single time of arrival and profile of the 
contrast bolus, and models accumulation relative to that arrival 
time.  In the Willmann et al. 2017 study data, it is not 
uncommon for lesions to have multiple feeding blood vessels, 
as well as vessels that fold back on themselves and appear 
multiple times in the same imaging plane.  This creates an 
overlapping multiplicity of bolus arrival times that can make it 
somewhat challenging to fit model parameters.  A promising 
area for future work would be to examine ways to employ 
multiple overlapping compartment models of the form 
suggested by Turco et al. to account for these deviations from 
the idealized single arrival time first-pass model.  
C. Overcoming Contrast-mode Tissue Leakage 
A popular alternative to bubble destruction is tissue 
background subtraction using a reference image acquired prior 
to contrast bolus arrival.   When post-contrast and pre-contrast 
images are perfectly aligned, subtraction will eliminate the 
tissue leakage background.  However, due to patient motion, 
organ motion, probe motion, and changes to probe orientation, 
using a pre-contrast reference frame, or even an average of 
several pre-contrast frames, as the basis for subtraction 
throughout a 60-90 second imaging session is only minimally 
effective.  In particular, out-of-plane motion of the probe, which 
is common, can cause an area of tissue leakage signal that is not 
present in the pre-contrast reference frame to suddenly appear 
and be misinterpreted as contrast agent accumulation.  
Additionally, varying probe pressure can dynamically change 
the pattern of the tissue leakage signal, creating changes in 
background signal that can go well beyond simple translation 
or rotation.  This necessitates use of a tissue leakage removal 
method that accounts for lateral and out-of-plane motion, for 
tissue compression due to varying applied probe pressure, and 
for the intermittent nature of signal leakage through harmonic 
contrast-mode filters. 
  
IV. COMPUTATIONAL ENHANCEMENT SYSTEM 
ARCHITECTURE 
Our computational enhancement system architecture, shown 
in Figure 2, encompasses four distinct computational 
enhancement modules: 
1. Tissue leakage disambiguation. 
2. Cross-window intensity analysis to distinguish non-
specific from specific binding. 
3. Flow disambiguation. 
4. Automatic ROI identification. 
This article focuses on the tissue leakage and flow 
disambiguation modules, showing results obtained with only 
those two enhancements activated.   
V. TISSUE LEAKAGE DISAMBIGUATION 
A. Tissue Leakage Modeling via Multi-Frame Fusion  
To non-destructively identify tissue leakage signal, we utilize 
a tissue leakage modeling approach that fuses multiple frames 
captured over the course of 30-45 seconds (at one frame per 
second) prior to contrast-agent bolus arrival.  This multi-frame 
fusion forms an estimate of which spatial locations potentially 
contain tissue leakage signal components.  The use of an 
extended period of time to observe pre-contrast arrival signals 
permits the effect of patient and operator-induced probe motion 
to be captured and represented.  It also provides ample time for 
intermittent tissue leakage signals that occasionally evade the 
ultrasound machine’s contrast-mode filters to be detected and 
to be incorporated into the tissue leakage model. 
For early disease screening, to minimize false positives, use 
of a highly conservative modeling approach is desirable.  Any 
contrast signal that is detected prior to contrast arrival, even if 
only present momentarily, is considered to be tissue leakage 
signal throughout the examination, so as to minimize false 
positive detections.  For this purpose, we have found that a 
Maximum Intensity Projection (MaxIP) across 30 or more pre-
contrast frames is quite effective, as illustrated in Figure 5, 
which shows that the pre-contrast MaxIP approach substantially 
improves lesion/normal contrast ratio relative to use of a 
traditional single frame background model.  For applications 
such as tumor margin detection for pre-surgical planning, a less 
aggressive background model is preferable, erring in favor of 
classifying a questionable intermittent signal as tumor, to 
ensure that tumor margins are not underestimated.  This paper 
focuses on the early disease screening scenario, using the 
maximum intensity projection approach. 
The maximum intensity projection interprets contrast signal 
observed in any frame prior to contrast bolus arrival to be tissue 
leakage background signal, generating a composite tissue 
leakage model image (Figure 3). Empirically, across the 18 
human breast imaging cases we have studied, this maximum 
intensity projection approach to background modeling has 
proven to be an effective approximation of the range of probe 
and patient motion that is exhibited a few seconds later during 
the period of contrast bolus arrival.   
B. Quantifying Examination Quality: The Spread Ratio  
Probe and patient movement during the pre-contrast arrival 
period leads to background signal associated with tissue 
leakage to appear to be laterally shifted in the case of in-plane 
probe/patient relative motion, or to appear or disappear (for out-
of-plane probe/patient motion).  When the maximum intensity 
projection is applied across multiple pre-contrast arrival image 
frames, image displacement due to probe-patient relative 
motion leads to enlargement or ‘spreading’ of tissue leakage 
background signal intensity, and to persistence of intermittent 
tissue leakage signal.  This ‘spreading’ may be quantified by 
taking the ratio of the overall intensity (across all pixels) of the 
fused background signal model to the overall intensity of a 
single pre-contrast arrival frame. In the ideal case of absence of 
patient motion, probe motion, and measurement error, this ratio 
will be 1. As motion increases, the ratio increases, as the image 
intensity spreads across multiple pixels of the maximum 
intensity projection.  
The spread ratio can serve as a measure of examination 
quality that may be used to further validate the confidence level 
in the diagnostic conclusions drawn from the molecular 
imaging data, i.e. whether the samples gathered after contrast 
bolus arrival can be expected to be free of substantial motion 
artifacts.  As illustrated in Figure 4, while most examinations 
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Figure 2: System Architecture Block Diagram 
Figure 3: Tissue leakage signal prior to contrast arrival (case 16).  
Left: Tissue leakage model derived from a single frame.  Right: 
Composite model derived from multi-frame maximum intensity fusion 
across 34 pre-contrast arrival frames.  Note how the nature of the 
intermittent tissue leakage signal, captured in the multi-frame fusion, 
if not removed could easily be misinterpreted as being due to contrast 
agent, even though there is no contrast agent present. 
  
have modest spread ratios, case #5 exhibits substantially more 
probe-patient relative motion, which is captured in the elevated 
spread ratio.  The spread ratio can be used to provide real-time 
feedback to the ultrasound operator, indicating whether a 
sufficient level of probe and patient stability have been 
achieved to warrant release of the contrast agent bolus.  
VI. FLOWING CONTRAST AGENT DISAMBIGUATION 
A. Advantages of imaging during bolus arrival 
Due to molecular binding of bubbles to target molecules, 
molecular ultrasound offers a unique opportunity to obtain still 
images post wash-in, after the flow of contrast agent has 
subsided. However, there are substantial advantages to imaging 
during wash-in.  First, not waiting for the flow to subside 
dramatically decreases the time elapsed from the construction 
of the tissue leakage background subtraction model to the time 
of measurement, thereby minimizing changes in probe and 
patient positioning during contrast bolus arrival relative to those 
present prior to bolus arrival.  Second, imaging during wash-in 
permits the binding accumulation rate to be captured, which can 
help distinguish between specific and non-specific binding.  
Third, significant unbinding occurs while waiting for the flow 
of contrast agent to subside, so the signal from bound contrast 
agent is stronger when imaging soon after molecular binding 
occurs.  Far greater contrast between lesion and normal tissue 
is available through computationally-enhanced imaging during 
wash-in rather than waiting several minutes for contrast agent 
flow to subside. 
Distinguishing stationary contrast agent from flowing 
contrast agent is extremely difficult for human readers to 
achieve in the presence of a high concentration of flowing 
contrast agent, since contrast agent appears throughout the field 
of view, as shown in Figure 1.  Detailed intensity analysis of 
individual pixels and time points makes it possible to readily 
estimate macro-scale properties such as contrast bolus arrival 
time and wash-in duration, but it is not at all clear from the raw 
data (Figure 6) what portion of the contrast agent intensity is 
due to molecularly bound contrast agent vs. flowing contrast 
agent.  To overcome flow disambiguation challenges, the 
radiologists reading the results of the initial human breast 
imaging study primarily utilized later time points, several 
minutes after contrast bolus arrival, after the high concentration 
of flowing contrast agent had subsided.   
B. Flow Disambiguation using Temporal Windowing 
Stationary contrast agent can be distinguished from flowing 
contrast agent using time-based windowing techniques.  As 
illustrated in Figure 7, samples captured by the ultrasound 
Cineloop are grouped into overlapping time windows.  These 
Figure 6: Examples of unprocessed CEUS data during the first 45 
seconds after contrast bolus administration.  Red: a single pixel 
signal from a tumor lesion.  Green: A single pixel signal from a 
normal tissue region.  (Case 17/151). 
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Figure 5: Comparison of Tissue Leakage Background Signal Modeling 
Methods.  Once flowing contrast agent has been removed, in this case 
using the Minimum Intensity Projection method described in [2], 
disambiguation of lesion vs. normal can be further improved through 
removal of tissue leakage signal using the multi-frame maximum-
intensity-projection model.   
  
windows are each used for statistical analysis, within windows 
to estimate accumulation level and across windows for 
accumulation rate estimation. 
Grouping samples into windows is advantageous because it 
permits analysis of samples over relatively smaller time scales 
during which key parameters such as mean signal intensity are 
more uniform than is the case over larger time periods.  For the 
breast imaging dataset [1], we have found window size W=20 
to be effective at a sample rate of 1 sample per second. 
C. Flow disambiguation within a temporal window 
In the absence of measurement error or noise, for low to 
moderate concentrations of non-stationary contrast agent, the 
minimum intensity projection (MinIP) across the samples in a 
time window will reflect the portion of the signal in that 
window that is due to stationary contrast agent particles.  When 
concentration of flowing contrast agent is low, it is likely that 
the measurement window will include at least one sample for 
which no flowing contrast agent particles is present at a 
particular pixel/region.  If one waits long enough after contrast 
agent injection prior to measuring, flowing contrast agent 
concentration will have decreased sufficiently that there will be 
several such samples within a measurement window.   
The availability of multiple valid samples without flow 
permits the use of alternative projections that are more resilient 
to measurement noise, such as the 20% projection (PerIP) 
approach suggested in [2], that takes the intensity of the weakest 
20% of samples to be reflective of the concentration of bound 
contrast agent.  The PerIP approach provides resilience to drop-
out measurement noise in which a single time sample has an 
erroneously low value. 
In high flow situations the MinIP approach becomes error 
prone because there will be flowing contrast agent present in all 
of the acquired samples within each window.  The projection 
no longer reflects the intensity due only to the non-flowing 
contrast agent signal, but also includes intensity associated with 
some of the flowing contrast agent.  If one uses the PerIP 
approach, the situation gets even worse, since in high flow, 
finding a window in which 20% of the samples are not due to 
flowing contrast agent is nearly impossible.  To address this 
issue, we developed an alternative method that can estimate 
stationary contrast agent concentration within a window even 
when it cannot be observed directly due to presence of flowing 
contrast agent.   
D. Statistical estimation approach 
The detailed dynamics of blood flow in normal and lesion 
tissue encountered in the human breast data set are quite 
complex.  Some lesions are fed by more than one blood supply 
source.  Vessels follow tortuous trajectories and may loop back 
towards the lesion, creating multiple ‘arrival times’.  There tend 
to be multiple binding sites present within each pixel, with 
multiple probabilistic events contributing to the overall 
observed intensity. Due to the central limit theorem, a 
combination of random variables tends towards the normal 
distribution.  Thus contrast agent accumulation may be 
approximated based on aggregate dynamic effects using the 
statistical mean-offset approach outlined below.  
The contribution of contrast agent accumulation to the overall 
observed signal is estimated based on statistical properties 
across the entire collection of samples within the measurement 
time-window, rather than relying on one minimum sample 
value as the MinIP approach does.  The statistical approach 
models the stationary contrast agent intensity at each location 
‘s’ in terms of standard deviations below the mean at that 
location: 
 𝑠 = 𝑚𝑎𝑥	(0, 𝑢 − 𝛼 σ )  
Equation 1: Statistical estimation (mean-offset) approach 
 
In Equation 1, σ is the standard deviation of the intensity of 
the samples within the window, 𝑢 is the mean intensity of the 
samples within the window, and 𝛼 is an algorithmic parameter 
to be selected and tuned.  We have found that it is effective to 
use a single value of 𝛼 across all 18 cases in the Willmann 
breast imaging data set [1], rather than adjusting 𝛼 for each 
patient. 𝛼 = 1.7 produces images that are visually 
indistinguishable from those produced by the Minimum 
Intensity Projection.   
Relative to the MinIP approach, the statistical approach with 
moderate value of 𝛼 provides greater resilience to single-
sample dropout noise and reduced latency response to intensity 
increases.  This provides finer time-resolution information for 
cross-window estimation of accumulation rate, which can help 
in disambiguation of specific from non-specific binding. 
To qualitatively estimate the intensity level that is due to 
bound contrast agent, which in high flows is not directly visible 
via minimum intensity projection, it is effective to increase 𝛼, 
which has the effect of reducing the intensity level estimates 
across the image in a manner that is flow-dependent.  For 
qualitative imaging purposes, for early disease detection 𝛼 = 2.7 
has been found to be quite effective across all 18 cases to 
optimize the contrast between lesion and normal tissue while 
minimizing flow-based imaging artifacts.  We anticipate that in 
clinical practice, 𝛼 may be predetermined, or may be tuned 
manually (for instance the equivalent of a ‘contrast’ knob on a 
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Figure 7: Measurement windowing approach, grouping adjacent 
samples to form statistical measurement windows.  For example, 
window #3 includes samples #3,#4,#5,#6, and #7. 
  
display) until imaging artifacts disappear from the non-lesion 
portions of an image. Alternatively, 𝛼 can be tuned 
automatically to optimize image quality metrics. 
E. Advantages of the Statistical Approach 
The statistical mean-offset approach is advantageous in part 
because mean and standard deviation are properties computed 
from consideration of all samples within the measurement 
window, reducing sensitivity to a single noisy reading (which 
could produce a false minimum value). More importantly, this 
approach does not require availability of a sample in which no 
flowing contrast agent is present, making it suitable for imaging 
scenarios that involve high concentrations of flowing contrast 
agent.  
Finally, when window-based analysis results are analyzed 
across multiple overlapping windows to produce accumulation 
rate estimates, the statistical approach provides finer time 
resolution information about contrast agent accumulation levels 
within each window than the minimum intensity projection 
does.  In the statistical approach, accumulation level updates 
occur continuously as each new data point is received. In 
contrast, for the Minimum Intensity Projection approach for a 
window of size W, a single MINIMUM sample value persists 
over the course of W measurement windows, masking details 
of further accumulation.  Hence during washin the MinIP 
approach provides accumulation information as a series of steps 
occurring every W windows, while the statistical approach 
provides finer time-resolution information. Availability of finer 
time resolution information opens the door to development of 
methods to disambiguate regions of molecularly-specific 
accumulation of contrast agent from regions of non-specific 
accumulation (such as blood vessels) based on accumulation 
rate information obtained via cross-window analysis of the 
accumulation levels exposed by the statistical approach to 
computational enhancement. 
F. Morphological Processing 
The statistical estimation approach produces sufficiently high 
contrast ratios between lesion and normal tissue that it becomes 
practical to apply morphological processing operations to fill-
in tiny spatial gaps without causing undo amplification of non-
accumulation signals.  For the results reported in this article, a 
morphological closure operation using a disk-shaped 
structuring element of radius 2-pixels was applied to the flow-
removed image prior to tissue leakage removal.   
VII. COMPUTATIONAL ENHANCEMENT RESULTS 
Figure 8 shows the results of applying the statistical approach 
to the raw data example shown in Figure 6.  For comparison 
purposes, the Minimum Intensity Projection results are also 
shown.  The delineation between normal and lesion tissues 
becomes quite clear.  This added clarity is reflected visually in 
the image-based results in Figure 10 and in the Lesion/Normal 
contrast ratio improvement factor in Figure 9. 
As shown in Figure 9 and Figure 11, in comparison to the 
approach used in the first-in-human study of waiting for the 
flow of contrast agent to subside [1], our computational 
enhancement approach, using a combination of maximum 
intensity projection tissue-leakage signal removal and statistical 
estimation-based flow-removal, achieves substantially 
improved lesion/contrast ratio and eliminates a false positive 
result (case #6).  Additionally, Figure 12 shows a comparison 
of the improvements made available via the statistical approach 
in comparision to the MinIP approach, during the high 
concentration of flowing contrast agent that is present when 
imaging during contrast bolus arrival. 
VIII. CONCLUSIONS 
mCEUS imaging in humans without use of bubble 
destruction, in the presence of patient motion, probe motion, 
and organ motion, with imaging geometries that include 
significant amounts of tissue leakage, poses unique challenges 
relative to imaging in immobile laboratory animals in which 
imaging protocols that incorporate bubble destruction can be 
utilized.      We have shown that these challenges can be 
overcome, making it practical to image contrast accumulation 
in humans during and shortly after contrast bolus arrival, 
without having to wait for the flow of contrast agent to subside.  
This early analysis, while flowing contrast agent is still present 
in high concentration, permits imaging when the signal is 
strongest, before substantial unbinding or bubble destruction 
occurs.  
Accounting for tissue leakage by using a background model 
that accounts for patient, probe, and local tissue motion 
substantially improves the lesion/normal contrast ratio, helping 
to prevent intermittent appearance and disappearance of tissue 
leakage signal from being mistaken for contrast agent 
accumulation.  The use of statistical estimation methods to 
predict the amount of contrast agent accumulation, rather than 
relying on occasional direct observation of contrast 
accumulation, or requiring that the bolus arrival match a pre-
envisioned model, permits analysis even at high flow rates 
without incurring undue false positive results.  
Figure 8: Statistical estimation  of accumulation for the raw data 
shown in Figure 6.  Red = tumor; Green = normal.  Vertical tick mark: 
MinIP accumulation estimate.  Circular tick mark: Statistical mean-
offset accumulation estimates (α = 2.5). 
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Figure 9: Comparison of Lesion/Normal contrast ratios.  Imaging during bolus arrival, with appropriate processing, provides vastly improved 
ability to distinguish lesions from normal tissue (Gold bars), relative to imaging later after the flow of contrast agent has largely subsided 
(Purple bars). Case 6 is a false positive (benign lesion) that the Flow&Tissue Leakage disambiguation software correctly eliminated.  For the 
statistical flow removal approach, 𝛼 = 2.7 was used for all cases. 
Figure 10: Typical Computational Enhancement Results.  Top left: Raw contrast image frame.  Top center: Image frame with multi-frame 
fusion tissue leakage removal applied.  Top right: Image derived from minimum-intensity-projection based reflection removal with window 
size W=20.  Bottom left: Image with BOTH minimum-intensity flow removal and tissue leakage removal applied.  Note how the two 
optimizations in combination provide a dramatic improvement.  Bottom center: Image frame with statistical flow removal applied, using 𝛼 = 2.7.  Bottom right: Image frame with BOTH statistical flow removal and multi-frame fusion tissue leakage removal applied.  Comparing 
the bottom left and bottom-right images illustrates that the statistical flow removal method removes imaging artifacts related to high flow 
rates that the minimum intensity projection approach is unable to remove.   
The outlined regions indicate pathology-proven lesion (right outlined region) vs. normal tissue (left outlined region). 
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Figure 11: Imaging via computational enhancement during contrast bolus arrival yields substantial 
improvement in lesion/normal contrast ratio (a key measure of tumor detectability) in comparison to 
imaging ~11 minutes later, after flow of contrast agent has subsided.  Using the statistical method with 𝛼 = 2.7, the contrast ratio improves in all cases, often by an order of magnitude or more.  For case #6, 
the contrast ratio in the computationally-enhanced result drops to 0, eliminating a false positive result 
in the 11-minute data associated with background tissue leakage that falsely appeared to be a tumor. 
Figure 12: For high flow situations, such as occurs during contrast bolus arrival, the Statistical 
Approach (𝛼 = 2.7) provides a substantial improvement in lesion/normal contrast ratio relative to the 
Minimum Intensity Projection (MinIP) approach.   
  
Even after flow signal removal and tissue leakage signal 
removal, occasional minor artifacts remain in the images, 
whose removal should be addressed by future work.  Primary 
among these is accumulation of contrast agent for reasons other 
than molecularly specific binding.   
 
For future improvements, we are developing cross-window 
optimizations that apply constraints based on accumulation rate 
to further distinguish specific binding from other sources of 
contrast agent accumulation.  For example, a large blood vessel 
filled with contrast agent will arrive quite suddenly in the field 
of view, filling with contrast agent and saturating the ultrasound 
detectors far more rapidly than does accumulation due to 
specific binding. Applying rate-based modeling to 
computational enhancement results has potential to enable 
models along the lines of the innovative work of Turco [5] [11] 
to be applied to data from which the flowing contrast agent 
signal has been removed.  This minimizes the impact of contrast 
agent flow dynamics (for instance multiple feeding blood 
vessels) and contrast bolus injection rate on the accumulation 
rate estimates.   
 In conclusion, the combination of tissue leakage elimination 
and statistics-based flow disambiguation provides an order of 
magnitude improvement in the ability to detect, characterize, 
and delineate regions of contrast agent accumulation relative to 
the analysis after flow has subsided approach used in the 
Willmann 2017 first-in-human study of BR-55 breast imaging. 
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